Apollomics(APLMW)
FOSTER CITY, CA
Biotechnology2 H-1B visas (FY2023)Focus: Cancer medicines
Apollomics is a life sciences company focused on Cancer medicines.
Oncology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
APL-101
BioequivalenceClinical Trials (1)
NCT05367388A Study Comparing Two Different Capsules, APL-101 and PLB-1001 Capsules, in Healthy Chinese and Caucasian Participants
Phase 1Uproleselan
Relapsed/Refractory AMLClinical Trials (1)
NCT04839341Study to Evaluate PK and Safety With Uproleselan Combined With Chemotherapy to Treat Chinese R/R AML Patients
Phase 1APL-501
Solid TumorClinical Trials (1)
NCT03053466APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors
Phase 1APL-102 Capsules
Advanced Solid TumorClinical Trials (1)
NCT05055518APL-102 Capsule in Patients With Advanced Solid Tumors
Phase 1Phase 1/2
Clinical Trials (1)
NCT04743505Safety and Efficacy of Combining APL-101 With Frontline Osimertinib in Patients With EGFR-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)
Phase 1/2APL-501
Hepatocellular CarcinomaClinical Trials (1)
NCT03655613APL-501 or Nivolumab in Combination With APL-101 in Locally Advanced or Metastatic HCC and RCC
Phase 1/2APL-101 Oral Capsules
Solid TumorsClinical Trials (1)
NCT03175224APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Phase 2Uproleselan
Relapsed/Refractory AMLClinical Trials (1)
NCT05054543Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AML
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 8 clinical trials
H-1B (2023): 2 approvals
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
2
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub